• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低磷酸酯酶症中股骨骨折的病理生理学

Pathophysiology of Femoral Fractures in Hypophosphatasia.

作者信息

Tabegna Fabiana G A, Garton Mark, D'Amore Simona, Skingle Linda, Dillon Scott, Duer Melinda J, Clunie Gavin P R, Poole Kenneth E S

机构信息

NIHR Cambridge Biomedical Research Centre, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.

Wrexham Glyndwr University, Clywd & Nuffield Health, Wrexham, Shrewsbury, Shropshire, United Kingdom.

出版信息

Curr Osteoporos Rep. 2025 Sep 4;23(1):36. doi: 10.1007/s11914-025-00929-y.

DOI:10.1007/s11914-025-00929-y
PMID:40906226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12411579/
Abstract

PURPOSE OF REVIEW

In this review, we will examine the pathophysiology, anatomy, biochemistry, and genotype-phenotype correlation of femoral fractures in adult hypophosphatasia.

RECENT FINDINGS

Hypophosphatasia (HPP) is a rare genetic disease characterized by low activity of tissue-nonspecific alkaline phosphatase (TNAP). The disease presents a broad spectrum of clinical manifestations primarily determined by the degree of residual TNAP activity. Adults with HPP of moderate clinical severity may present with spontaneous femoral fractures that are like the atypical femoral fractures (AFF) of long-term bisphosphonates users. In this review, we will focus on the paradox that while HPP can cause biopsy-proven osteomalacia (pathologically impaired bone mineralisation), the spontaneous femoral fractures that characterise adult HPP do not exhibit typical osteomalacia features. Instead, they resemble the femoral fractures that occur in other diseases such as osteopetrosis where bone becomes excessively dense, brittle and highly mineralised due to osteoclast dysfunction. This review examines the key aspects of the pathophysiology of femoral fractures in adults with HPP, offering new insights into the role of anatomical, molecular and biochemical bone abnormalities that characterise the disease. Further investigations of HPP patients with femoral fracture are needed to examine the nanoscale crystal structure of the bone and to study abnormalities in fracture healing and bone resorption.

摘要

综述目的

在本综述中,我们将探讨成人低磷性骨软化症股骨骨折的病理生理学、解剖学、生物化学以及基因型 - 表型相关性。

最新发现

低磷性骨软化症(HPP)是一种罕见的遗传性疾病,其特征为组织非特异性碱性磷酸酶(TNAP)活性降低。该疾病呈现出广泛的临床表现,主要由残余TNAP活性程度决定。临床严重程度为中度的成人HPP患者可能会出现自发性股骨骨折,这些骨折类似于长期使用双膦酸盐类药物患者的非典型股骨骨折(AFF)。在本综述中,我们将聚焦于这样一个矛盾现象:虽然HPP可导致经活检证实的骨软化症(病理上骨矿化受损),但成人HPP特征性的自发性股骨骨折却不表现出典型的骨软化症特征。相反,它们类似于其他疾病(如石骨症)中发生的股骨骨折,在石骨症中,由于破骨细胞功能障碍,骨骼变得过度致密、脆弱且矿化程度高。本综述探讨了成人HPP患者股骨骨折病理生理学的关键方面,为该疾病特征性的解剖学、分子和生物化学骨异常的作用提供了新的见解。需要对患有股骨骨折的HPP患者进行进一步研究,以检查骨骼的纳米级晶体结构,并研究骨折愈合和骨吸收的异常情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/7f220dfba64e/11914_2025_929_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/064ab254adc6/11914_2025_929_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/7df483e53c3f/11914_2025_929_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/88fb01ee35c0/11914_2025_929_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/fae734ce439a/11914_2025_929_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/f94b149b781d/11914_2025_929_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/7f220dfba64e/11914_2025_929_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/064ab254adc6/11914_2025_929_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/7df483e53c3f/11914_2025_929_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/88fb01ee35c0/11914_2025_929_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/fae734ce439a/11914_2025_929_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/f94b149b781d/11914_2025_929_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/12411579/7f220dfba64e/11914_2025_929_Fig6_HTML.jpg

相似文献

1
Pathophysiology of Femoral Fractures in Hypophosphatasia.低磷酸酯酶症中股骨骨折的病理生理学
Curr Osteoporos Rep. 2025 Sep 4;23(1):36. doi: 10.1007/s11914-025-00929-y.
2
Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval.关于阿法骨化醇酶在低磷性骨软化症中有效性的临床研究及真实世界证据的关键经验总结:获批后10年
Adv Ther. 2025 Jul 25. doi: 10.1007/s12325-025-03309-1.
3
Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B metabolism.吡哆醇激发试验反映了儿童低磷酸酶血症的严重程度,从而检验了组织非特异性碱性磷酸酶在维生素 B 代谢中的作用。
Bone. 2024 Apr;181:117033. doi: 10.1016/j.bone.2024.117033. Epub 2024 Feb 1.
4
Preclinical evaluation of the efficacy and safety of adeno-associated virus 8-tissue-nonspecific alkaline phosphatase-D10 in Alpl-/- and AlplPrx1/Prx1 mouse models for the treatment of early and late-onset hypophosphatasia.腺相关病毒8-组织非特异性碱性磷酸酶-D10在Alpl-/-和AlplPrx1/Prx1小鼠模型中治疗早发性和晚发性低磷酸酯酶症的疗效和安全性的临床前评估
J Bone Miner Res. 2025 Apr 21;40(4):463-477. doi: 10.1093/jbmr/zjaf005.
5
Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.低磷酸酯酶症患者的股骨转子下和骨干骨折——根本不足为奇。
Osteoporos Int. 2018 Aug;29(8):1815-1825. doi: 10.1007/s00198-018-4552-3. Epub 2018 May 17.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Clinical presentation of adults with persistently low alkaline phosphatase activity: a retrospective multicentre, cross-sectional study in Germany.成年人体内碱性磷酸酶活性持续偏低的临床表现:德国一项回顾性多中心横断面研究
BMJ Open. 2025 Jul 1;15(7):e097235. doi: 10.1136/bmjopen-2024-097235.
8
Dentoalveolar defects and impaired alveolar bone healing in a neural crest directed conditional knockout mouse model of hypophosphatasia.低磷酸酯酶症神经嵴定向条件性敲除小鼠模型中的牙槽骨缺损及牙槽骨愈合受损
Bone. 2025 Sep;198:117538. doi: 10.1016/j.bone.2025.117538. Epub 2025 May 19.
9
Hypophosphatasia in Adults: Clinical Spectrum and Its Association With Genetics and Metabolic Substrates.成人低磷酸酯酶症:临床谱及其与遗传学和代谢底物的关系。
J Clin Densitom. 2020 Jul-Sep;23(3):340-348. doi: 10.1016/j.jocd.2018.12.006. Epub 2018 Dec 21.
10
Fractures are Highly Correlated with Bone Density and Inversely Correlated with Bone Turnover Markers in Autosomal Dominant Osteopetrosis.在常染色体显性遗传性骨硬化症中,骨折与骨密度高度相关,与骨转换标志物呈负相关。
J Bone Miner Res. 2025 Sep 6. doi: 10.1093/jbmr/zjaf123.

本文引用的文献

1
Mobility and Quality of Life in Adults with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access Agreement.接受阿法骨化醇治疗的儿童期起病低磷酸酯酶症成人患者的活动能力和生活质量:英国管理式准入协议的结果
Adv Ther. 2025 May;42(5):2429-2444. doi: 10.1007/s12325-025-03168-w. Epub 2025 Mar 26.
2
Preclinical evaluation of the efficacy and safety of adeno-associated virus 8-tissue-nonspecific alkaline phosphatase-D10 in Alpl-/- and AlplPrx1/Prx1 mouse models for the treatment of early and late-onset hypophosphatasia.腺相关病毒8-组织非特异性碱性磷酸酶-D10在Alpl-/-和AlplPrx1/Prx1小鼠模型中治疗早发性和晚发性低磷酸酯酶症的疗效和安全性的临床前评估
J Bone Miner Res. 2025 Apr 21;40(4):463-477. doi: 10.1093/jbmr/zjaf005.
3
Prevalence of chondrocalcinosis and calcium pyrophosphate deposition disease in a cohort of adult patients with low alkaline phosphatase levels and a positive versus negative genetic study.一组碱性磷酸酶水平低的成年患者中软骨钙质沉着症和焦磷酸钙沉积病的患病率及基因研究阳性与阴性情况
JBMR Plus. 2024 Sep 26;8(11):ziae124. doi: 10.1093/jbmrpl/ziae124. eCollection 2024 Nov.
4
The Global ALPL gene variant classification project: Dedicated to deciphering variants.全球 ALPL 基因变异分类项目:致力于破解变异。
Bone. 2024 Jan;178:116947. doi: 10.1016/j.bone.2023.116947. Epub 2023 Oct 26.
5
Carriers of autosomal recessive conditions: are they really 'unaffected?'.常染色体隐性遗传病携带者:他们真的“未受影响”吗?
J Med Genet. 2023 Dec 21;61(1):1-7. doi: 10.1136/jmg-2023-109563.
6
Atypical Femoral Fracture in Hypophosphatasia: A Systematic Review.低磷性骨软化症中的非典型股骨骨折:一项系统评价
Int J Endocrinol. 2023 Sep 12;2023:5544148. doi: 10.1155/2023/5544148. eCollection 2023.
7
The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase.由功能失调的组织非特异性碱性磷酸酶引起的低磷酸酯酶症的结构病理学。
Nat Commun. 2023 Jul 8;14(1):4048. doi: 10.1038/s41467-023-39833-3.
8
Hypophosphatasia: from birth to adulthood.低磷酸酯酶症:从出生到成年。
Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626.
9
Osteomalacia in Adults: A Practical Insight for Clinicians.成人骨软化症:临床医生的实用见解
J Clin Med. 2023 Apr 5;12(7):2714. doi: 10.3390/jcm12072714.
10
Urine phosphoethanolamine is a specific biomarker for hypophosphatasia in adults.尿磷乙醇胺是成人低磷酸酶血症的特异性生物标志物。
Bone. 2022 Oct;163:116504. doi: 10.1016/j.bone.2022.116504. Epub 2022 Jul 22.